In the scrum

7 September 2017 By Neil Unmack

The UK fund manager has been hit by huge slumps in AstraZeneca and Provident Financial. Markets are faddish, as he points out. But blaming dud picks on the gap between what’s publicly disclosed and reality is hard to square with his fondness for making big bets on single firms.

This content is for Subscribers only

To access full Breakingviews.com content you must be a subscriber. Please use the following link to request a trial.

 

Email a friend

Please complete the form below.

Required fields *

*
*
*

(Separate multiple email addresses with commas)